MedTrace Logo

Perfusion Imaging and CT -Understanding Relative Efficacy

NCT00486447 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 249

Last updated 2017-08-23

Study results available
· View outcomes & findings →

Summary

To determine the relative efficacy of Cardiac Computed Tomography Angiography (CCTA) and Single Positron Emission Computed Tomography (SPECT) in patients with an intermediate risk of CAD.

Conditions

Interventions

DEVICE

64 Channel VCT

cardiac CT angiography exam

Sponsors & Collaborators

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Matthew Budoff · LA Biomedical Research Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-04-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00486447 on ClinicalTrials.gov